PENNSYLVANIA
|
No.
23-0993790
|
(State
or other jurisdiction of
incorporation
or organization)
|
(I.R.S.
Employer
Identification
No.)
|
One
Quaker Park
901
Hector Street
Conshohocken,
Pennsylvania 19428
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|
(610)
832-4000
|
(Registrant’s
telephone number, including area code)
|
|
(Former
name or former address, if changed since last
report)
|
Exhibit
No.
|
|
99.1
|
Press
Release of Quaker Chemical Corporation dated August 1, 2007.
|
QUAKER
CHEMICAL CORPORATION
Registrant
|
||
|
|
|
Date: August 1, 2007 | By: | /s/ Mark A. Featherstone |
Mark
A. Featherstone
Vice
President and
Chief
Financial Officer
|
||
For
Release:
Immediate
|
NEWS
|
Contact:
Mark
A. Featherstone
Vice
President and
Chief
Financial Officer
610-832-4160
|
Quaker
Chemical Corporation
|
|||||||||||||
Condensed
Consolidated Statement of Income
|
|||||||||||||
(Dollars
in thousands, except per share data and share
amounts)
|
|||||||||||||
(Unaudited)
|
|||||||||||||
Three
Months Ended June 30,
|
Six
Months Ended June 30,
|
||||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Net
sales
|
$
|
137,598
|
$
|
118,683
|
$
|
262,489
|
$
|
228,499
|
|||||
Cost
of goods sold
|
94,986
|
82,618
|
181,331
|
159,949
|
|||||||||
Gross
margin
|
42,612
|
36,065
|
81,158
|
68,550
|
|||||||||
%
|
31.0
|
%
|
30.4
|
%
|
30.9
|
%
|
30.0
|
%
|
|||||
Selling,
general and administrative expenses
|
35,409
|
29,789
|
67,328
|
57,151
|
|||||||||
Operating
income
|
7,203
|
6,276
|
13,830
|
11,399
|
|||||||||
%
|
5.2
|
%
|
5.3
|
%
|
5.3
|
%
|
5.0
|
%
|
|||||
Other
income, net
|
909
|
387
|
1,236
|
515
|
|||||||||
Interest
expense, net
|
(1,501
|
)
|
(1,252
|
)
|
(2,851
|
)
|
(2,217
|
)
|
|||||
Income
before taxes
|
6,611
|
5,411
|
12,215
|
9,697
|
|||||||||
Taxes
on income
|
2,298
|
2,127
|
4,142
|
3,680
|
|||||||||
4,313
|
3,284
|
8,073
|
6,017
|
||||||||||
Equity
in net income of associated companies
|
266
|
125
|
391
|
238
|
|||||||||
Minority
interest in net income of subsidiaries
|
(428
|
)
|
(417
|
)
|
(776
|
)
|
(721
|
)
|
|||||
Net
income
|
$
|
4,151
|
$
|
2,992
|
$
|
7,688
|
$
|
5,534
|
|||||
%
|
3.0
|
%
|
2.5
|
%
|
2.9
|
%
|
2.4
|
%
|
|||||
Per
share data:
|
|||||||||||||
Net
income - basic
|
$
|
0.42
|
$
|
0.31
|
$
|
0.77
|
$
|
0.57
|
|||||
Net
income - diluted
|
$
|
0.41
|
$
|
0.30
|
$
|
0.76
|
$
|
0.56
|
|||||
Shares
Outstanding:
|
|||||||||||||
Basic
|
9,983,535
|
9,769,682
|
9,945,819
|
9,746,685
|
|||||||||
Diluted
|
10,118,653
|
9,833,117
|
10,074,060
|
9,824,968
|
Quaker
Chemical Corporation
|
|||||||
Condensed
Consolidated Balance Sheet
|
|||||||
(Dollars
in thousands, except par value and share
amounts)
|
|||||||
(Unaudited)
|
|||||||
June
30,
|
December
31,
|
||||||
2007
|
2006
|
||||||
ASSETS
|
|||||||
Current
assets
|
|||||||
Cash
and cash equivalents
|
$
|
14,517
|
$
|
16,062
|
|||
Accounts
receivable, net
|
124,652
|
107,340
|
|||||
Inventories,
net
|
57,379
|
51,984
|
|||||
Prepaid
expenses and other current assets
|
13,204
|
10,855
|
|||||
Total
current assets
|
209,752
|
186,241
|
|||||
Property,
plant and equipment, net
|
60,890
|
60,927
|
|||||
Goodwill
|
41,108
|
38,740
|
|||||
Other
intangible assets, net
|
8,270
|
8,330
|
|||||
Investments
in associated companies
|
6,786
|
7,044
|
|||||
Deferred
income taxes
|
32,517
|
28,573
|
|||||
Other
assets
|
31,941
|
27,527
|
|||||
Total
assets
|
$
|
391,264
|
$
|
357,382
|
|||
LIABILITIES
AND SHAREHOLDERS' EQUITY
|
|||||||
Current
liabilities
|
|||||||
Short-term
borrowings and current portion of long-term debt
|
$
|
2,147
|
$
|
4,950
|
|||
Accounts
and other payables
|
64,159
|
56,345
|
|||||
Accrued
compensation
|
11,661
|
15,225
|
|||||
Other
current liabilities
|
15,212
|
13,659
|
|||||
Total
current liabilities
|
93,179
|
90,179
|
|||||
Long-term
debt
|
96,247
|
85,237
|
|||||
Deferred
income taxes
|
5,761
|
5,317
|
|||||
Other
non-current liabilities
|
74,409
|
61,783
|
|||||
Total
liabilities
|
269,596
|
242,516
|
|||||
Minority
interest in equity of subsidiaries
|
4,807
|
4,035
|
|||||
Shareholders'
equity
|
|||||||
Common
stock, $1 par value; authorized 30,000,000 shares; issued
10,106,214
shares
|
10,106
|
9,926
|
|||||
Capital
in excess of par value
|
8,452
|
5,466
|
|||||
Retained
earnings
|
112,342
|
114,498
|
|||||
Accumulated
other comprehensive loss
|
(14,039
|
)
|
(19,059
|
)
|
|||
Total
shareholders' equity
|
116,861
|
110,831
|
|||||
Total
liabilities and shareholders' equity
|
$
|
391,264
|
$
|
357,382
|
Quaker
Chemical Corporation
|
|||||||
Condensed
Consolidated Statement of Cash Flows
|
|||||||
For
the Six Months Ended June 30,
|
|||||||
(Dollars
in thousands)
|
|||||||
(Unaudited)
|
|||||||
2007
|
2006
|
||||||
Cash
flows from operating activities
|
|||||||
Net
income
|
$
|
7,688
|
$
|
5,534
|
|||
Adjustments
to reconcile net income to net cash used in operating
activities:
|
|||||||
Depreciation
|
5,500
|
4,893
|
|||||
Amortization
|
611
|
708
|
|||||
Equity
in net income of associated companies, net of dividends
|
(26
|
)
|
(33
|
)
|
|||
Minority
interest in earnings of subsidiaries
|
776
|
721
|
|||||
Deferred
income tax
|
452
|
334
|
|||||
Deferred
compensation and other, net
|
824
|
61
|
|||||
Stock-based
compensation
|
561
|
385
|
|||||
(Gain)
loss on disposal of property, plant and equipment
|
6
|
(8
|
)
|
||||
Insurance
settlement realized
|
(913
|
)
|
(157
|
)
|
|||
Pension
and other postretirement benefits
|
(1,773
|
)
|
(2,752
|
)
|
|||
Increase
(decrease) in cash from changes in current assets and
current liabilities,
net of acquisitions:
|
|||||||
Accounts
receivable
|
(14,785
|
)
|
(8,746
|
)
|
|||
Inventories
|
(3,921
|
)
|
(2,011
|
)
|
|||
Prepaid
expenses and other current assets
|
(989
|
)
|
(2,449
|
)
|
|||
Accounts
payable and accrued liabilities
|
3,123
|
1,475
|
|||||
Change
in restructuring liabilities
|
-
|
(3,411
|
)
|
||||
Net
cash used in operating activities
|
(2,866
|
)
|
(5,456
|
)
|
|||
Cash
flows from investing activities
|
|||||||
Capital
expenditures
|
(4,180
|
)
|
(4,863
|
)
|
|||
Payments
related to acquisitions
|
(1,527
|
)
|
(1,069
|
)
|
|||
Proceeds
from disposition of assets
|
106
|
46
|
|||||
Insurance
settlement received and interest earned
|
5,326
|
154
|
|||||
Change
in restricted cash, net
|
(4,413
|
)
|
3
|
||||
Net
cash used in investing activities
|
(4,688
|
)
|
(5,729
|
)
|
|||
|
|||||||
Cash
flows from financing activities
|
|||||||
Net
decrease in short-term borrowings
|
(2,841
|
)
|
(2,813
|
)
|
|||
Proceeds
from long-term debt
|
10,921
|
14,340
|
|||||
Repayments
of long-term debt
|
(448
|
)
|
(474
|
)
|
|||
Dividends
paid
|
(4,304
|
)
|
(4,199
|
)
|
|||
Stock
options exercised, other
|
2,605
|
335
|
|||||
Distributions
to minority shareholders
|
(270
|
)
|
(350
|
)
|
|||
Net
cash provided by financing activities
|
5,663
|
6,839
|
|||||
Effect
of exchange rate changes on cash
|
346
|
336
|
|||||
Net
decrease in cash and cash equivalents
|
(1,545
|
)
|
(4,010
|
)
|
|||
Cash
and cash equivalents at the beginning of the period
|
16,062
|
16,121
|
|||||
Cash
and cash equivalents at the end of the period
|
$
|
14,517
|
$
|
12,111
|